A Roadmap to Cardiac Tissue‐Engineered Construct Preservation: Insights from Cells, Tissues, and Organs
Open Access
- 28 May 2021
- journal article
- review article
- Published by Wiley in Advanced Materials
- Vol. 33 (27) , 2008517
Abstract
Worldwide, over 26 million patients suffer from heart failure (HF). One strategy aspiring to prevent or even to reverse HF is based on the transplantation of cardiac tissue‐engineered (cTE) constructs. These patient‐specific constructs aim to closely resemble the native myocardium and, upon implantation on the diseased tissue, support and restore cardiac function, thereby preventing the development of HF. However, cTE constructs off‐the‐shelf availability in the clinical arena critically depends on the development of efficient preservation methodologies. Short‐ and long‐term preservation of cTE constructs would enable transportation and direct availability. Herein, currently available methods, from normothermic‐ to hypothermic‐ to cryopreservation, for the preservation of cardiomyocytes, whole‐heart, and regenerative materials are reviewed. A theoretical foundation and recommendations for future research on developing cTE construct specific preservation methods are provided. Current research suggests that vitrification can be a promising procedure to ensure long‐term cryopreservation of cTE constructs, despite the need of high doses of cytotoxic cryoprotective agents. Instead, short‐term cTE construct preservation can be achieved at normothermic or hypothermic temperatures by administration of protective additives. With further tuning of these promising methods, it is anticipated that cTE construct therapy can be brought one step closer to the patient.Keywords
Funding Information
- Technische Universiteit Eindhoven
- European Commission (ERC‐2014‐StG, 635928)
- Fundação para a Ciência e a Tecnologia (PTDC/BTMSAL/32566/2017)
This publication has 116 references indexed in Scilit:
- Normal Left Ventricular Myocardial Thickness for Middle-Aged and Older Subjects With Steady-State Free Precession Cardiac Magnetic ResonanceCirculation: Cardiovascular Imaging, 2012
- Protection of Rat Cardiac Myocytes by Fructose-1,6-Bisphosphate and 2,3-ButanedionePLOS ONE, 2012
- Cryopreservation of Human Embryonic Stem Cells Derived-Cardiomyocytes Induced by BMP2 in Serum-Free ConditionReproductive Sciences, 2011
- Organ Preservation: Current Concepts and New Strategies for the Next DecadeTransfusion Medicine and Hemotherapy, 2011
- Pre-treatment with a DPP-4 Inhibitor is Infarct Sparing in Hearts from Obese, Pre-diabetic RatsCardiovascular Drugs and Therapy, 2010
- Polyampholytes as low toxic efficient cryoprotective agents with antifreeze protein propertiesBiomaterials, 2009
- Protein Stability in IceBiophysical Journal, 2007
- Blockade of Electron Transport before Cardiac Ischemia with the Reversible Inhibitor Amobarbital Protects Rat Heart MitochondriaThe Journal of Pharmacology and Experimental Therapeutics, 2006
- Prolonged 24-hour subzero preservation of heterotopically transplanted rat hearts using antifreeze proteins derived from arctic fishThe Annals of Thoracic Surgery, 2004
- Fructose-1,6-diphosphate and a glucose-free solution enhances functional recovery in hypothermic heart preservationThe Journal of Heart and Lung Transplantation, 2000